Quarterly Results

BROOKS LABORATORIES LTD.

NSE : BROOKSBSE : 533543ISIN CODE : INE650L01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE108.922.13 (+1.99 %)
PREV CLOSE ( ) 106.79
OPEN PRICE ( ) 108.92
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1108
TODAY'S LOW / HIGH ( )108.92 108.92
52 WK LOW / HIGH ( )56.5 185.15
NSE108.952.1 (+1.97 %)
PREV CLOSE( ) 106.85
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4522
TODAY'S LOW / HIGH( ) 108.95 108.95
52 WK LOW / HIGH ( )56.95 185.7
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
Audited
UnAudited
UnAudited
UnAudited
Net Sales
217.47
243.15
157.03
126.14
Total Expenditure
206.51
225.99
156.78
127.34
PBIDT (Excl OI)
10.96
17.16
0.25
-1.2
Other Income
1.55
0.92
0.55
0.19
Operating Profit
12.51
18.08
0.79
-1.01
Interest
2.13
1.87
1.71
1.84
Exceptional Items
NA
NA
NA
NA
PBDT
10.38
16.21
-0.91
-2.85
Depreciation
4.35
4.41
4.41
4.36
Profit Before Tax
6.03
11.8
-5.32
-7.21
Tax
0.26
NA
0.00
0.00
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
5.77
11.8
-5.32
-7.21
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
5.77
11.8
-5.32
-7.21
Minority Interest
NA
NA
0.00
0.00
Shares of Associates
-44.56
-28.18
-39.38
-35.79
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-38.79
-16.37
-44.7
-42.99
Equity Capital
262.47
262.47
247.03
247.03
Face Value (IN RS)
10
10
10
10
Reserves
492.51
492.51
492.51
627.87
Calculated EPS
-1.47
-0.62
-1.80
-1.74
Calculated EPS (Annualised)
-5.91
-2.49
-7.23
-6.96
No of Public Share Holdings
9556031
9556031
8296563
8296563
% of Public Share Holdings
36.41
36.41
33.59
33.59
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
5.03
7.05
0.15
-0.95
PBIDTM%
5.75
7.43
0.50
-0.80
PBDTM%
4.77
6.66
-0.57
-2.25
PBTM%
2.77
4.85
-3.38
-5.71
PATM%
2.65
4.85
-3.38
-5.71
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.